BROOKE CASEY: Open Payments
NPI 1407044803 · WILKES BARRE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,373 in 64 payments from 14 companies in 2025. Trend: 2023 $351 · 2024 $1,103 · 2025 $1,373
Food & beverage: $1,290Education: $83
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $349 |
| UCB, Inc. | 9 | $172 |
| Regeneron Healthcare Solutions, Inc. | 4 | $171 |
| ABBVIE INC. | 16 | $165 |
| GENZYME CORPORATION | 5 | $136 |
| Organon LLC | 6 | $103 |
| Lilly USA, LLC | 3 | $63 |
| Galderma Laboratories, L.P. | 3 | $58 |
| Amgen Inc. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, HADLIMA, TALTZ, Otezla, Sotyktu.
Industry payments across PA — which companies pay providers there.
